Fresh analysis indicates that patients who discontinue blockbuster slimming jabs like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who end traditional lifestyle regimens.
Findings released in a major medical journal demonstrates that while overweight people can lose about a fifth of their total mass while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"People buying these medications need to be cognizant of the danger of quick weight regain when the therapy ends," cautioned researcher Dr. Susan Jebb.
That rate of regain implies a reversion to pre-treatment weight in about a year and a half.
Comparing Approaches
The research, which examined 37 of trials involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with other pills.
Scientists emphasize that individuals who lose weight through diet and exercise usually see a slower weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Quick Regain
Nutrition scientists believe the way of the drugs is key to understanding the accelerated regain.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication leads to hunger is no longer kept in check, making overeating a significant risk."
A Chronic Disease?
Health authorities suggest the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals say that, given the high risk of weight regain, the treatment might need to be long-term.
This opinion is supported by drug manufacturers, who state that the results "highlight the chronic character of obesity," comparing it to managing diseases like hypertension.
User Testimonies
Individuals who have stopped the jabs describe a sudden return of hunger.
"It was like a trigger activating and you become ravenous," recalled an individual.
This challenge is exacerbated if users have not adopted permanent lifestyle or habit modifications during therapy.
Widespread Adoption
Figures suggest that millions of people in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Use is greater among females compared to males.
- The middle-aged age group shows the highest usage rates.
- A large proportion obtain the drugs through private healthcare rather than public health services.
Finally, researchers caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a magic fix and lasting health benefits likely depends on combined lifestyle support.
